tiprankstipranks
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market
SYRE
Spyre Therapeutics
RESEARCH TOOLSreports

Spyre Therapeutics (SYRE) Cash flow

531 Followers

Spyre Therapeutics Cash Flow

SYRE's free cash flow for Q4 2025 was $-44.58M. For the 2025 fiscal year, SYRE's free cash flow was decreased by $-11.84M and operating cash flow was $-44.58M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -169.25M$ -157.41M$ -99.91M$ -80.14M$ -53.72M
Investing Cash Flow
$ -143.47M$ -353.29M$ -108.39M$ 57.01M$ -22.62M
Financing Cash Flow
$ 309.02M$ 410.91M$ 361.08M$ 42.68M$ 1.39M
End Cash Position
$ 85.72M$ 89.42M$ 189.22M$ 36.42M$ 16.98M
Free Cash Flow
$ -169.25M$ -157.41M$ -99.91M$ -80.18M$ -54.29M
Currency in USD

Spyre Therapeutics Cash Flow